Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE BEAUVAL 2 : revenue, balance sheet and financial ratios

SELARL PHARMACIE BEAUVAL 2 is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MEAUX (77100), this company of category PME shows in 2020 a revenue of 2.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE BEAUVAL 2 (SIREN 822070926)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C 2 557 875 € N/C N/C N/C
Net income 269 059 € 131 590 € 118 252 € 198 660 € 140 342 € 121 470 € 157 317 € 123 171 € 115 330 €
EBITDA N/C N/C N/C N/C N/C 272 008 € N/C N/C N/C
Net margin N/C N/C N/C N/C N/C 4.7% N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE BEAUVAL 2 generates positive net income of 269 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 115 k€ -> 269 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

269 059 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

42.242%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

58.016%

Solvency indicators evolution
SELARL PHARMACIE BEAUVAL 2

Sector positioning

Debt ratio
42.24 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good -12 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE BEAUVAL 2 (42.24) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
58.02% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +12 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE BEAUVAL 2 (58.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE BEAUVAL 2

Positioning of SELARL PHARMACIE BEAUVAL 2 in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE BEAUVAL 2 is estimated at 4 274 034 € (range 2 900 379€ - 6 706 548€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2900k€ 4274k€ 6706k€
4 274 034 € Range: 2 900 379€ - 6 706 548€
NAF 5 année 2025

Valuation method used

Net Income Multiple
269 059 € × 15.9x = 4 274 034 €
Range: 2 900 380€ - 6 706 548€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE BEAUVAL 2 with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE BEAUVAL 2

What is the revenue of SELARL PHARMACIE BEAUVAL 2 ?

The revenue of SELARL PHARMACIE BEAUVAL 2 in 2020 is 2.6 M€.

Is SELARL PHARMACIE BEAUVAL 2 profitable?

Yes, SELARL PHARMACIE BEAUVAL 2 generated a net profit of 269 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE BEAUVAL 2 ?

The headquarters of SELARL PHARMACIE BEAUVAL 2 is located in MEAUX (77100), in the department Seine-et-Marne.

Where to find the tax return of SELARL PHARMACIE BEAUVAL 2 ?

The tax return of SELARL PHARMACIE BEAUVAL 2 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE BEAUVAL 2 operate?

SELARL PHARMACIE BEAUVAL 2 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.